|
Volumn 14, Issue 3, 2002, Pages 183-198
|
Preventing drug-related morbidity - Determining valid indicators
|
Author keywords
Adverse drug events; Delphi technique; Preventable drug related morbidity; Primary care; United Kingdom; United States
|
Indexed keywords
AMINOGLYCOSIDE DERIVATIVE;
AMIODARONE;
ANTIBIOTIC AGENT;
ANTITHYROID AGENT;
BARBITURIC ACID DERIVATIVE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBAMAZEPINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EYE DROPS;
HISTAMINE H2 RECEPTOR ANTAGONIST;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMIPRAMINE;
LAXATIVE;
METOCLOPRAMIDE;
NARCOTIC ANALGESIC AGENT;
NEDOCROMIL;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHENYTOIN;
POTASSIUM;
POTASSIUM SPARING DIURETIC AGENT;
PROTON PUMP INHIBITOR;
TETRACYCLINE;
THYROID HORMONE;
UNINDEXED DRUG;
VERAPAMIL;
WARFARIN;
ADULT;
ANEMIA;
ARTICLE;
BLEEDING;
BLOOD DYSCRASIA;
CONSTIPATION;
CONTROLLED STUDY;
DISEASE EXACERBATION;
DRUG INDUCED DISEASE;
DRUG SURVEILLANCE PROGRAM;
FEMALE;
GENERAL PRACTITIONER;
HEALTH CARE QUALITY;
HEALTH CARE SYSTEM;
HEALTH PRACTITIONER;
HEART BLOCK;
HUMAN;
HYPERKALEMIA;
HYPERTHYROIDISM;
HYPOKALEMIA;
JAUNDICE;
MALE;
MEDICAL RECORD;
MORBIDITY;
PHARMACIST;
PRESCRIPTION;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
QUESTIONNAIRE;
UNITED KINGDOM;
UNITED STATES;
UNIVERSITY;
URINE RETENTION;
VALIDATION PROCESS;
|
EID: 0036086230
PISSN: 13534505
EISSN: None
Source Type: Journal
DOI: 10.1093/oxfordjournals.intqhc.a002610 Document Type: Article |
Times cited : (70)
|
References (29)
|